These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1549369)
1. Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Narayanan R; Lawlor KG; Schaapveld RQ; Cho KR; Vogelstein B; Bui-Vinh Tran P; Osborne MP; Telang NT Oncogene; 1992 Mar; 7(3):553-61. PubMed ID: 1549369 [TBL] [Abstract][Full Text] [Related]
2. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Rao VN; Shao N; Ahmad M; Reddy ES Oncogene; 1996 Feb; 12(3):523-8. PubMed ID: 8637708 [TBL] [Abstract][Full Text] [Related]
3. Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Lawlor KG; Narayanan R Cell Growth Differ; 1992 Sep; 3(9):609-16. PubMed ID: 1419911 [TBL] [Abstract][Full Text] [Related]
4. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Reale MA; Hu G; Zafar AI; Getzenberg RH; Levine SM; Fearon ER Cancer Res; 1994 Aug; 54(16):4493-501. PubMed ID: 8044801 [TBL] [Abstract][Full Text] [Related]
5. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Klingelhutz AJ; Hedrick L; Cho KR; McDougall JK Oncogene; 1995 Apr; 10(8):1581-6. PubMed ID: 7731713 [TBL] [Abstract][Full Text] [Related]
6. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers. Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364 [TBL] [Abstract][Full Text] [Related]
7. DCC expression is altered by multiple mechanisms in brain tumours. Ekstrand BC; Mansfield TA; Bigner SH; Fearon ER Oncogene; 1995 Dec; 11(11):2393-402. PubMed ID: 8570191 [TBL] [Abstract][Full Text] [Related]
8. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786 [TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
10. The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules. Fearon ER; Pierceall WE Cancer Surv; 1995; 24():3-17. PubMed ID: 7553661 [TBL] [Abstract][Full Text] [Related]
11. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300 [TBL] [Abstract][Full Text] [Related]
12. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene. Velcich A; Corner G; Palumbo L; Augenlicht L Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603 [TBL] [Abstract][Full Text] [Related]
13. The NF-kappaB transcription factor in oncogenesis. Sharma HW; Narayanan R Anticancer Res; 1996; 16(2):589-96. PubMed ID: 8687102 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Maret A; Galy B; Arnaud E; Bayard F; Prats H Cancer Res; 1995 Nov; 55(21):5075-9. PubMed ID: 7585554 [TBL] [Abstract][Full Text] [Related]
15. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B. Yam JW; Chan KW; Hsiao WL Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504 [TBL] [Abstract][Full Text] [Related]
16. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594 [TBL] [Abstract][Full Text] [Related]
17. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524 [TBL] [Abstract][Full Text] [Related]
18. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
19. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis. Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Thiagalingam S; Lengauer C; Leach FS; Schutte M; Hahn SA; Overhauser J; Willson JK; Markowitz S; Hamilton SR; Kern SE; Kinzler KW; Vogelstein B Nat Genet; 1996 Jul; 13(3):343-6. PubMed ID: 8673134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]